[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study. - Nault JC; Boubaya M; Wartski M; Dohan A; Pol S; Pop G; Soussan M; Sutter O; Costentin C; Roux J; Sengel C; Lequoy M; et al. (The lancet. Gastroenterology & hepatology, 2025)